ClinicalTrialsFinder

CIMCA-Hemato-Oncology ( Site 0380)

San José, Provincia de San José, Costa Rica

1 recruiting

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Metastatic Castration-resistant Prostate Cancer (mCRPC)Prostatic Neoplasms
Merck Sharp & Dohme LLC1,314 enrolled324 locationsNCT06136650